| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00097 | 1 |